Events

The future of swedish and danish life science for cross disciplinary collaborations.

During this high-level seminar and partnering meeting, Scottish speakers will demonstrate the dynamic regenerative medicine community. After a morning seminar, Scottish and Nordic biotechnology companies will get the opportunity to take part in a networking lunch followed by one-to-one meetings.

Selecting compliance systems is a complex challenge for any size of regulated company. QAtor will present his experiences from the pharma industry.

Selecting compliance systems is a complex challenge for any size of regulated company. QAtor will present his experiences from the pharma industry.

We are pleased to invite you to Medicon Valley Alliance in Ørestad City, Copenhagen, Denmark, for a one-day event on RoHS implementation in medical device and diagnostics industries.

Cryopreserved peripheral blood mononuclear cells (PBMC) provide an excellent alternative to fresh PBMC as a tool for assay validation, phenotypic analysis, and functional immunological studies. Optimal retention of PBMC functionality during cryopreservation depends on optimized and standardized cell isolation, freezing, and storage…

All pharmaceuticals need to undergo extensive clinical testing and even testing before clinical trials. Protocols must be published prior to the trials and the regulatory authorities also contribute to publications.

The release of the updated EMA GDP guidelines will have a huge impact on the industry. There has never been a more relevant time to have a unique platform dedicated to discuss the key challenges that you and your peers are facing in the field of Quality Assurance and Regulatory Affairs.

All pharmaceuticals need to undergo extensive clinical testing and even testing before clinical trials. Protocols must be published prior to the trials and the regulatory authorities also contribute to publications.

As the Chinese Life Science industry undergo major changes, new business opportunities arise for Medicon Valley Life Science companies. This seminar aims to highlight these business opportunities and will give participants an insight into the commercial opportunities for pharma, biotech and medtech on the Chinese market.

We are pleased to invite you to Medicon Valley Alliance in Ørestad City, Copenhagen, Denmark, for a one-day event on Innovations in Clinical Development.

How do Payers and Biopharma build new relationships to manage costs and drive innovation and jobs into the future? Dr Christoph Schnorr, Vice President, Quintiles Drug Development Consulting, will share real insights around it

It gives us great pleasure to be able to invite you to a morning with mHealth & eHealth focus. We aim for, by taking off in where we stand today and looking at where we could be tomorrow, find a common focus that could span the Öresund region.

The EU patent has been underway for more than 30 years but now finally seems to become a reality. This will create new possibilities and challenges for European companies and universities. Patent experts from Høiberg will guide you through the future European patent landscape as it will look when the EU patent and Unified Patent Court…

The EU patent has been underway for more than 30 years but now finally seems to become a reality. This will create new possibilities and challenges for European companies and universities. Patent experts from Høiberg will guide you through the future European patent landscape as it will look when the EU patent and Unified Patent Court…

Requirements for cell based assays have induced a rapid development of novel cell models. To improve the effectiveness of target research and compound development the use of patient or stem cell-derived cell models is becoming increasingly important. SIRION Biotech specializes in viral vector technology and provides sophisticated cell…

Nisch seminar with 100 drug formulation professionals and other representatives from pharmaceutical companies in the Nordic Countries.

Nisch seminar with 100 drug formulation professionals and other representatives from pharmaceutical companies in the Nordic Countries.

Building on the success from April’s seminar, Medicon Valley Alliance in cooperation with DNB invites you to participate in a second network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present your technology / business plan to any of the…

Get updated on recent events and find out how you can benefit from your membership. If you are not yet a member, come and discuss your opportunities with us. The meeting is an excellent opportunity for you to meet and network with MVA members.

Medicon Valley Alliance’s new initiative Science Forum 2013 will highlight areas in which the academic system and industry can improve in order to attract world class talent to Medicon Valley thereby increasing our global competitiveness. The focus will be on current challenges within academic life science research in Sweden and Denmark…

The first Good Morning Ambassador Meeting in 2013 will focus on eHealth solutions and status of telemedicine in two highly interesting countries, Japan and South Korea. Note that this event will be held in Sweden 25 February and in Denmark 26 February!

The first Good Morning Ambassador Meeting in 2013 will focus on eHealth solutions and status of telemedicine in two highly interesting countries, Japan and South Korea. Note that this event will be held in Sweden 25 February and in Denmark 26 February!

As the size and complexity of large scientific datasets increases, life sciences teams from industry and academic are using cloud computing to deliver results more quickly, at larger scale and more cost effectively. Medicon Valley Alliance in collaboration with Amazon Web Services is excited to invite you to a morning of lively discussion…

The life science industry as a whole is under tremendous pressure for several reasons. Ending patens, rising costs on new therapies in conjunction with a reduction in public spending – just to name a few. In the future we need more for less. How do the conditions of outsourcing look in the future and how do sponsors and vendors in Medicon…